⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

September 3, 2024

[Clinical characteristics and prognostic analysis of thoracic SMARCA4-deficient undifferentiated tumor].

Xitao Wang Yujun Kang Haiyi Wang Weihui Shi Xiao Yan Yahui Liu T M Jeena Shiliang Li Jianqiang Jin

View Full Paper

Ask AI

Bookmark

Share

Abstract

To summarize and analyze the clinical characteristics and prognosis of thoracic SMARCA4-deficient undifferentiated tumor (SMARCA4-UT).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Wang et al. (2024) studied this question.

synapsesocial.com/papers/68e597e1b6db6435875328d3 https://doi.org/10.3760/cma.j.cn112137-20240417-00902

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1SMARCA4‐Deficient Undifferentiated Thoracic Tumor: Clinical Features and Prognosis of a Case Series and Literature ReviewPrognostic Study · 2026
2Thoracic SMARCA4-deficient tumors: a clinicopathological analysis of 52 cases with SMARCA4-deficient non-small cell lung cancer and 20 cases with thoracic SMARCA4-deficient undifferentiated tumor2024 · 16 citations
3[Clinical characteristics and prognosis analysis of 17 cases of SMARCA4-deficient chest tumors].2024 · 1 citations
4Treatment of Thoracic SMARCA4-Deficient Undifferentiated Tumors: Where We Are and Where We Will Go2024 · 45 citations
5A case of surgically treated non-metastatic SMARCA4-deficient undifferentiated thoracic tumor: a case report and literature review2024 · 4 citations